Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients with Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: the Phase 3 PREVENT Study (1780)
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.94.15_supplement.1780